Biocompatibility for Medical Devices US, Chicago 2019

Memo

Biocompatibility for Medical Devices US, this October in Chicago, will explore the updates to ISO 10993, the risk-based approach, chemical characterization and toxicological risk assessments. You will have the chance to learn from ISO/TC 194 representatives about the latest requirements and methods available to ensure they maintain compliance. Professionals within the biocompatibility industry will benefit from the conference's focus on industry hot topics, such as skin sensitivity testing, animal welfare requirements, blood interactions and toxicokinetic study design for degradation products and leachables. Throughout the conference, there will be plenty of opportunities to network with like-minded peers and experts in the field, to develop and deepen their knowledge of biocompatibility testing and evaluations. In addition to the conference, a pre-conference workshop will be run to take those new to the industry, or requiring a refresher, through the fundamentals of biocompatibility. For sponsorship/exhibition opportunities, please get in touch. URLs:Tickets: https://go.evvnt.com/497294-2?pid=5569Sponsor: https://go.evvnt.com/497294-3?pid=5569 Prices:Conference Pass - Early Savings: Register by Friday, September 13 2019: USD 1495.0,Conference Pass: USD 1595.0 Speakers: Kelly P. Coleman, Technical Fellow and Distinguished Toxicologist | Medtronic, Jianwei Li, Tehnical Fellow and Senior Chemistry Manager | Medtronic, Michael F. Wolf, Technical Fellow and Bakken Fellow Corporate Technology and Innovation | Medtronic, Christian Pellevoisin, Scientific Director | Episkin Academy, Ted Heise, Vice President Regulatory and Clinical Services | MED Institute, Thor Rollins, Director of Toxicology | Nelson Labs, Beau Rollins, Director of Quality Services | ConvaTec Date and Time: On Thursday October 24, 2019 at 9:00 am (ends Friday October 25, 2019 at 6:00 pm) Venue Details: JW Marriott Chicago, 151 West Adams Street, Chicago, 60603, United States